Back to today’s briefing

Story perspectives

FDA Approves First Eye Drops for Presbyopia Relief

8/9/2025

50 3

Summary

Story summary

The FDA has made a groundbreaking decision by approving VIZZ, the first-ever eye drop treatment for presbyopia, crafted by LENZ. This innovative aceclidine drop promises to clear near-object blurriness for up to 10 hours with minimal side effects. Set to hit prescriptions by late 2025, it offers hope to over 128 million Americans seeking clearer vision.

1 of 1

Story summary

The FDA has made a groundbreaking decision by approving VIZZ, the first-ever eye drop treatment for presbyopia, crafted by LENZ. This innovative aceclidine drop promises to clear near-object blurriness for up to 10 hours with minimal side effects. Set to hit prescriptions by late 2025, it offers hope to over 128 million Americans seeking clearer vision.